U.S. Indexes Drop Sharply
Stock futures moved lower Thursday, a day after the S&P 500 hit a fresh all-time high, while retail giant Walmart slid after issuing a disappointing outlook.Futures for the Dow Jones Industrials lost 140 points, or 0.3%, to 44,571Futures for the S&P 500 slid 17.75 points or 0.3%, to 6,145.25.Futures for the tech-heavy NASDAQ gave back 59.5 points, or 0.3%, to 22,191. Dow member Walmart dropped more than 7% after the company said it expects fiscal year sales to grow between 3% and 4%. That’s below a StreetAccount forecast that pointed to 4.2% growth. The company’s fiscal 2026 earnings outlook was also below analyst expectations. The weak guidance overshadowed fiscal fourth-quarter earnings that beat analyst expectations.Wall Street is coming off a winning session, with the S&P 500 on Wednesday posting another record high. The NASDAQ Composite and the 30-stock Dow also finished in positive territory as investors shrugged off President Donald Trump’s warning of more tariffs.Elsewhere on the economic front, investors will be watching for weekly jobless claims data, which is due at 8:30 a.m. ET.In Japan, the Nikkei 225 slid 1.2% Thursday, while in Hong Kong, the Hang Seng dropped 1.2%. Oil prices captured 22 cents to $72.47 U.S. a barrel. Gold prices hiked $24.50 to $2,960.60 U.S. an ounce.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


